Rosalie Wyonch – Ozempic: The Perils of Living Beside the US Elephant
From: Rosalie Wyonch To: Healthcare observers Date: July 22, 2024 Re: Ozempic: The Perils of Living Beside the US Elephant In the last instalment of our examination of the lessons of the Ozempic moment we look at the complications of living next door to the largest and highest profit pharmaceutical market in the world and ongoing changes to […] Rosalie Wyonch – Ozempic: Economic Ripple Effects, Equity and Side Effects
From: Rosalie Wyonch To: Healthcare Observers Date: July 18, 2024 Re: Ozempic: Economic Ripple Effects, Equity and Side Effects The surge in demand for Ozempic (and other GLP-1 medications) has implications for healthcare’s future, is creating opportunities for complementary products and services and disrupting other markets. About 6 percent of US adults currently use one of the drugs, according to […] Plotting Progress on Primary Care Access Strategies across Provinces
The lack of access to family physicians in Canada is a critical issue affecting millions of Canadians, and provinces are all moving to address it.This Graphic Intelligence illustrates primary care initiatives and actions taken by various provinces since 2022 in pursuit of five well-established approaches: increasing supply of family physicians; reducing administrative burdens; implementing alternative compensation […] Rosalie Wyonch – Ozempic: Disruption and Drama in Pharmaceutical Markets and Insurance
From: Rosalie Wyonch To: Healthcare Observers Date: July 17, 2024 Re: Ozempic: Disruption and Drama in Pharmaceutical Markets and Insurance Ozempic (and other GLP-1 medications) are having their moment in the popular mind. And their sudden prominence illustrates how pharmaceutical companies can expand the market for existing products by finding new applications. They have been approved as safe for […] Rosalie Wyonch – Ozempic: A Microcosm That Can Teach Us a Lot about Healthcare Markets
From: Rosalie Wyonch To: Healthcare Observers Date: July 16, 2024 Re: Ozempic: A Microcosm That Can Teach Us a Lot about Healthcare Markets Ozempic (and other GLP-1 medications) have been having their moment. Headlines hail a “miracle drug” for weight loss, others say that’s too good to be true, and there’s even a South Park episode titled “the end […] Tingting Zhang – Five Ways to Address our Family Physician Shortage
From: Tingting Zhang To: Canadian Healthcare Observers Date: July 2, 2024 Re: Five Ways to Address our Family Physician Shortage Canadians are in a primary-care paradox. About 14 percent of Canadians aged 12 and older – approximately 4.6 million people – did not have a regular health-care provider in 2022, according to Statistics Canada. Even more alarming, about 6.6 million Canadians […] Tingting Zhang – Canada has tons of doctors—yet an alarming number of people have no primary-care provider. What’s going on?
Published in The Hub
…The Doctor Dilemma with Tingting Zhang and Rosalie Wyonch
Solving Canada’s healthcare crisis requires a combination of strategic policy reforms, technological innovation, and a shift towards more collaborative care models. On this episode of the CDHI Podcast, policy analysts Tingting Zhang and Rosalie Wyonch tell host Michael Hainsworth about the five key strategies for success the provinces should be paying attention to.
The Doctor Dilemma: Improving Primary Care Access in Canada
The lack of access to family physicians is a critical issue in Canada, with millions of Canadians lacking access to a primary care provider. Shortages have been exacerbated by the pandemic, which led to notable levels of physician burnout and an increase in retirements. This Commentary estimates the shortages of family physicians in provinces […] Rosalie Wyonch – Fixing the ALC Patient Problem is a Triple Win for Canadians
To: Health Policymakers From: Rosalie Wyonch Date: May 10, 2024 Re: Fixing the ALC Patient Problem is a Triple Win for Canadians Hospitals are capacity constrained, more expensive and no place for patients who no longer need an acute-level bed. Yet, these Alternate Level Care (ALC) patients, represented 17 percent of all acute-care bed-days in Canada […] Healthcare Policy Initiative
Canada’s healthcare systems are under increasing pressure: a rapidly aging population, new demands for services, fiscal challenges, and awkward interfaces between publicly and privately funded services are among the challenges to which Canadians must adapt. Sound research and advice from independent sources will be integral to achieving desirable policy outcomes. The C.D. Howe Institute’s Healthcare […] Chris Bonnett – Aspiration and Ambiguity. That’s the Pharmacare Story
From: Chris Bonnett To: Pharmacare Watchers Date: April 24, 2024 Re: Aspiration and Ambiguity. That’s the Pharmacare Story For decades, pharmacare has been a day late and a dollar short. How much did Bill C-64 change that? Very few Canadians have no drug insurance, but a much larger number probably need more coverage. The lack of an integrated national drug system […]